285 related articles for article (PubMed ID: 31644603)
1. Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.
Cowppli-Bony A; Trétarre B; Marrer E; Defossez G; Daubisse-Marliac L; Coureau G; Minicozzi P; Woronoff AS; Delafosse P; Molinié F;
PLoS One; 2019; 14(10):e0224275. PubMed ID: 31644603
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study.
Pons-Tostivint E; Daubisse-Marliac L; Grosclaude P; Oum Sack E; Goddard J; Morel C; Dunet C; Sibrac L; Lagadic C; Bauvin E; Bergé Y; Bernard-Marty C; Vaysse C; Lacaze JLL;
Breast; 2019 Aug; 46():170-177. PubMed ID: 31226572
[TBL] [Abstract][Full Text] [Related]
3. Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
van Dam PA; Tomatis M; Marotti L; Heil J; Mansel RE; Rosselli Del Turco M; van Dam PJ; Casella D; Bassani LG; Danei M; Denk A; Egle D; Emons G; Friedrichs K; Harbeck N; Kiechle M; Kimmig R; Koehler U; Kuemmel S; Maass N; Mayr C; Prové A; Rageth C; Regolo L; Lorenz-Salehi F; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Audisio R; Ponti A;
Eur J Cancer; 2017 Nov; 85():15-22. PubMed ID: 28881247
[TBL] [Abstract][Full Text] [Related]
4. Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis.
Kiderlen M; Ponti A; Tomatis M; Boelens PG; Bastiaannet E; Wilson R; van de Velde CJ; Audisio RA;
Eur J Cancer; 2015 Jul; 51(10):1221-30. PubMed ID: 25892645
[TBL] [Abstract][Full Text] [Related]
5. 360 Health Analysis (H360)-A Comparison of Key Performance Indicators in Breast Cancer Management across Health Institution Settings in Portugal.
Rego IB; Coelho S; Semedo PM; Cavaco-Silva J; Teixeira L; Sousa S; Reis J; Dinis R; Schmitt F; Afonso N; Fougo JL; Pavão F; Baptista Leite R; Costa L
Curr Oncol; 2023 Jun; 30(7):6041-6065. PubMed ID: 37504311
[TBL] [Abstract][Full Text] [Related]
6. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Naume B; Nygård JF
Int J Med Inform; 2019 May; 125():102-109. PubMed ID: 30914174
[TBL] [Abstract][Full Text] [Related]
7. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer care compared with clinical Guidelines: an observational study in France.
Lebeau M; Mathoulin-Pélissier S; Bellera C; Tunon-de-Lara C; Daban A; Lipinski F; Jaubert D; Ingrand P; Migeot V;
BMC Public Health; 2011 Jan; 11():45. PubMed ID: 21251274
[TBL] [Abstract][Full Text] [Related]
9. Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators.
Héquet D; Huchon C; Baffert S; Alran S; Reyal F; Nguyen T; Combes A; Trichot C; Alves K; Berseneff H; Rouzier R
Br J Cancer; 2017 May; 116(11):1394-1401. PubMed ID: 28441385
[TBL] [Abstract][Full Text] [Related]
10. Quality indicators for breast cancer care: A systematic review.
Maes-Carballo M; Gómez-Fandiño Y; Reinoso-Hermida A; Estrada-López CR; Martín-Díaz M; Khan KS; Bueno-Cavanillas A
Breast; 2021 Oct; 59():221-231. PubMed ID: 34298301
[TBL] [Abstract][Full Text] [Related]
11. The process of EUSOMA certification improves the quality of breast cancer care: the experience of an Italian EUSOMA certificated Breast Unit (BU) according to the results of a cross-sectional study.
Gazzani D; Dai Prè A; Sandrini R; Governa M; Favaro A; Zogno A; Remo A; Greco F; Molinari E; Aguzzi G; Signorelli D; Caprara D; Costa L; Zanella C; Signorini M; Mercanti A; Giuliani J; Zambelli L; Majori S; Moretti F; Bonetti A
Recenti Prog Med; 2021 Jun; 112(6):458-464. PubMed ID: 34128938
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort.
Houzard S; Courtois E; Le Bihan Benjamin C; Erbault M; Arnould L; Barranger E; Coussy F; Couturaud B; Cutuli B; de Cremoux P; de Reilhac P; de Seze C; Foucaut AM; Gompel A; Honoré S; Lesur A; Mathelin C; Verzaux L; Bousquet PJ
Clin Breast Cancer; 2022 Oct; 22(7):e832-e841. PubMed ID: 35750594
[TBL] [Abstract][Full Text] [Related]
13. The effect of EUSOMA certification on quality of breast cancer care.
van Dam PA; Tomatis M; Marotti L; Heil J; Wilson R; Rosselli Del Turco M; Mayr C; Costa A; Danei M; Denk A; Emons G; Friedrichs K; Harbeck N; Kiechle M; Koheler U; Kuemmel S; Maass N; Marth C; Prové A; Kimmig R; Rageth C; Regolo L; Salehi L; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Ponti A; ;
Eur J Surg Oncol; 2015 Oct; 41(10):1423-9. PubMed ID: 26278019
[TBL] [Abstract][Full Text] [Related]
14. Quality indicators for ductal carcinoma in situ (DCIS) of the breast: development using a multidisciplinary delphi process and its use in monitoring population-based treatment.
Chin-Lenn L; Craighead P; Bryant HE; Mack L; Temple W; Ghali W; Quan ML
J Surg Oncol; 2013 Nov; 108(6):348-51. PubMed ID: 24038038
[TBL] [Abstract][Full Text] [Related]
15. Variation in rates of breast cancer surgery: A national analysis based on French Hospital Episode Statistics.
Rococo E; Mazouni C; Or Z; Mobillion V; Koon Sun Pat M; Bonastre J
Eur J Surg Oncol; 2016 Jan; 42(1):51-8. PubMed ID: 26490007
[TBL] [Abstract][Full Text] [Related]
16. EUSOMA quality indicators for non-metastatic breast cancer: An update.
Rubio IT; Marotti L; Biganzoli L; Aristei C; Athanasiou A; Campbell C; Cardoso F; Cardoso MJ; Coles CE; Eicher M; Harbeck N; Karakatsanis A; Offersen BV; Pijnappel R; Ponti A; Regitnig P; Santini D; Sardanelli F; Spanic T; Varga Z; Vrancken Peeters MJTFD; Wengström Y; Wyld L; Curigliano G
Eur J Cancer; 2024 Feb; 198():113500. PubMed ID: 38199146
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
[TBL] [Abstract][Full Text] [Related]
18. The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer.
Laliberte L; Fennell ML; Papandonatos G
Med Care; 2005 May; 43(5):471-9. PubMed ID: 15838412
[TBL] [Abstract][Full Text] [Related]
19. [A set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancer].
Russo A; Andreano A; Anghinoni E; Autelitano M; Bellini A; Bersani M; Bizzoco S; Cavalieri d'Oro L; Decarli A; Lucchi S; Mannino S; Panciroli E; Rognoni M; Sampietro G; Valsecchi MG; Villa M; Zocchetti C; Zucchi A
Epidemiol Prev; 2014; 38(1):16-28. PubMed ID: 24736958
[TBL] [Abstract][Full Text] [Related]
20. Adherence to guidelines for baseline staging in newly diagnosed localized breast cancer.
DeMiglio L; Murdoch V; Ivison J; Voutsadakis IA
Cancer Treat Res Commun; 2020; 22():100160. PubMed ID: 31677495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
